GSK PLC ADR (GSK) Social Stream
GSK PLC (GSK) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering GSK.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-05 | 8 | $52.5 | $41.5 | $47.75 | $39.64 | 20.46% |
| 2022-01-03 | 8 | $51 | $41.5 | $47.375 | $39.64 | 19.51% |
| 2022-01-17 | 7 | $51 | $44.2 | $48.733 | $39.64 | 22.94% |
| 2022-02-02 | 7 | $52.5 | $44.2 | $49.233 | $39.64 | 24.2% |
| 2022-02-14 | 7 | $52.5 | $46.3 | $49.933 | $39.64 | 25.97% |
| 2022-03-14 | 7 | $51.5 | $45.6 | $49.366 | $39.64 | 24.54% |
| 2022-04-05 | 7 | $55 | $45.6 | $50.533 | $39.64 | 27.48% |
| 2022-04-19 | 7 | $55 | $45.7 | $50.566 | $39.64 | 27.56% |
| 2022-04-21 | 7 | $55 | $44.5 | $50.166 | $39.64 | 26.55% |
| 2022-04-27 | 7 | $55 | $45.9 | $50.633 | $39.64 | 27.73% |
| 2022-05-31 | 6 | $52.5 | $45.9 | $49.8 | $39.64 | 25.63% |
| 2022-06-07 | 7 | $52.5 | $45.9 | $49.8 | $39.64 | 25.63% |
| 2022-06-16 | 7 | $51 | $45.9 | $49.133 | $39.64 | 23.95% |
| 2022-07-26 | 7 | $63.125 | $44.4 | $52.841 | $39.64 | 33.3% |
| 2022-08-13 | 7 | $63.125 | $43.5 | $52.541 | $39.64 | 32.55% |
| 2022-08-24 | 7 | $63.125 | $36 | $50.041 | $39.64 | 26.24% |
| 2022-09-19 | 7 | $51 | $34 | $40.333 | $39.64 | 1.75% |
| 2022-10-21 | 7 | $51 | $33 | $40 | $39.64 | 0.91% |
| 2022-11-01 | 7 | $51 | $33 | $40.666 | $39.64 | 2.59% |
| 2022-11-23 | 7 | $51 | $33 | $40.666 | $39.64 | 2.59% |
| 2022-12-04 | 7 | $51 | $33 | $40.666 | $39.64 | 2.59% |
| 2022-12-05 | 7 | $51 | $33 | $39.833 | $39.64 | 0.49% |
| 2022-12-07 | 7 | $51 | $33 | $40.066 | $39.64 | 1.07% |
| 2023-02-01 | 7 | $51 | $36.2 | $41.733 | $39.64 | 5.28% |
| 2023-04-20 | 7 | $51 | $35.5 | $41.833 | $39.64 | 5.53% |
| 2023-04-27 | 7 | $51 | $36 | $42 | $39.64 | 5.95% |
| 2023-07-05 | 7 | $45 | $36 | $40 | $39.64 | 0.91% |
| 2023-07-17 | 7 | $45 | $35 | $39.666 | $39.64 | 0.07% |
| 2023-09-12 | 6 | $45 | $35 | $39.833 | $39.64 | 0.49% |
| 2023-09-22 | 7 | $45 | $35 | $39.833 | $39.64 | 0.49% |
| 2023-11-01 | 7 | $45 | $35 | $40.166 | $39.64 | 1.33% |
| 2023-12-06 | 7 | $45 | $35 | $39.5 | $39.64 | -0.35% |
The Trend in the Analyst Price Target
Over the past 44 weeks, GSK's average price target has gone down $2.
Over the past 45 weeks, GSK's average upside potential has been 13.66%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-24 | 7 | 51 | 36.2 | 41.733 | 34.70 | 20.27% |
| 2023-07-05 | 7 | 45 | 36.0 | 40.000 | 34.73 | 15.17% |
| 2023-09-11 | 6 | 45 | 35.0 | 39.833 | 37.02 | 7.6% |
| 2023-09-22 | 7 | 45 | 35.0 | 39.833 | 37.43 | 6.42% |
| 2023-10-20 | 7 | 45 | 35.0 | 40.166 | 35.58 | 12.89% |
GSK Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3.71 | 0 | 0 | 4 | 2 | 2 | 7 |
The Trend in the Broker Recommendations
Over the past 25 months, GSK's average broker recommendation rating worsened by 0.96.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of stocks in the large market cap category, GSK PLC's number of analysts covering the stock is greater than 349% of them.
- GSK has a lower variance in analysts' estimates than -431.87% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, GSK PLC's upside potential (average analyst target price relative to current price) is higher than 699.03% of them.
- GSK has a greater average analyst price target than 916.51% of stocks in the large market cap category.
Stocks similar to GSK PLC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are GRFS, SNY, and GLPG.
View All Top Stocks by Price Target
Is GSK a Buy, Hold or Sell? See the POWR Ratings now!